The design of phase II trials

This publication has 11 references indexed in Scilit:

• Chemotherapy of Small Cell Lung Cancer
  Chest, 1989
• Evaluating new drugs in patients with chemosensitive tumours: ethical dilemmas in extensive small cell lung cancer
  Lung Cancer, 1989
• Ifosfamide in previously untreated disseminated neuroblastoma
  European Journal of Cancer and Clinical Oncology, 1988
• First-line chemotherapy rechallenge after relapse in small cell lung cancer
  Cancer Chemotherapy and Pharmacology, 1988
• Retreatment with the induction regimen in small cell lung cancer relapsing after an initial response to short term chemotherapy
  European Journal of Cancer and Clinical Oncology, 1987
• The prognostic value of response to the first cycle of chemotherapy in small cell lung cancer. Results of a multicenter German trial
  European Journal of Cancer and Clinical Oncology, 1987
• Phase II clinical and pharmacological study of oral 4-demethoxydaunorubicin in advanced non-pretreated small cell lung cancer
  Cancer Chemotherapy and Pharmacology, 1987
• Phase II study of 1,2,4-triglycidylurazol (TGU) previously untreated and treated patients with small cell lung cancer
  European Journal of Cancer and Clinical Oncology, 1987
• PROGNOSTIC IMPLICATIONS OF STAGE OF DISEASE AND SITES OF METASTASES IN PATIENTS WITH SMALL CELL-CARCINOMA OF THE LUNG TREATED WITH INTENSIVE COMBINATION CHEMOTHERAPY
  Published by Elsevier ,1981
• The determination of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agent
  Journal of Chronic Diseases, 1961